Back to search
FDAFDA · Food and drugs·Recall number D-0658-2016

Morphine Sulfate, 2 mg per mL (60 mg per 30 mL) 30 mL total volume in a 35 mL Monoject Barrel Syringes in Sodium Chloride 0.9%, Rx only, Contains Sulfites, Compounded Drug, Not for Resale, Hospital/Office Use only, IV use only, NDC 61553-401-44.

Published February 17, 2016 · Recall initiated: May 22, 2015

Summary

FDA records drug Class I recall D-0658-2016, published February 17, 2016 and initiated May 22, 2015. Recalling firm: Pharmedium Services, LLC; Status: Terminated; Reported quantity: 19 Syringes; Lot: Lot #:151370066M, Exp. 08/15/2015. Class I means a reasonable probability of serious adverse health consequences or death.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Sub-potent Drug; firm's analysis revealed subpotent result for morphine sulfate assay.

What to do

Voluntary: Firm initiated · Telephone

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Pharmedium Services, LLC
Distributor
WI
Lot
Lot #:151370066M, Exp. 08/15/2015
Risk classification
Class I
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Morphine Sulfate, 2 mg per mL (60 mg per 30 mL) 30 mL total volume in a 35 mL Monoject Barrel Syringes in Sodium Chloride 0.9%, Rx only, Contains Sulfites, Compounded Drug, Not for Resale, Hospital/Office Use only, IV use only, NDC 61553-401-44. recalled?

Yes. FDA published recall D-0658-2016 on February 17, 2016. Reported hazard: Sub-potent Drug; firm's analysis revealed subpotent result for morphine sulfate assay.

What should I do if I have this product?

Voluntary: Firm initiated · Telephone